Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants
Internal Medicine Journal · 2025
DOI: 10.1111/imj.16572 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2025. Verfasst von Joseph Raco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA. Hauptthemen laut MEDLINE: Paracentesis, Anticoagulants, Ascites, Venous Thromboembolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Penn State Milton S. Hershey Medical Center Department of Medicine Housestaff Grant.
Abstract (Originalsprache)
Background
Abdominal paracentesis is a frequently performed procedure in hospitalised patients with ascites. Concurrently, most hospitalised adult patients receive pharmacologic anticoagulation, either for therapeutic purposes or prophylactically to prevent venous thromboembolism. Despite this, minimal evidence exists to guide management of anticoagulant therapy pre‐ and post‐paracentesis.
Aims
The authors aimed to investigate the safety of abdominal paracentesis in hospitalised patients receiving therapeutic or prophylactic anticoagulation, including in patients for whom these medications were withheld periprocedurally.
Methods
TriNetX, an electronic health record data set, was queried to identify patients between the ages of 18 and 80 years who received an abdominal paracentesis while hospitalised at the authors' institution between September 2017 and June 2022. Patients receiving prophylactic anticoagulation (137), therapeutic anticoagulation (74) and no anticoagulation because of coagulopathy or thrombocytopenia (15) were compared. Rates of withholding anticoagulation, performing service, pre‐ and post‐paracentesis haemoglobin, bleeding complications, thrombotic complications and need for red blood cell transfusion were analysed.
Results
Procedure‐related bleeding complications occurred in two (1.4%) patients in the prophylactic group and 0 (0%) patients in the therapeutic group ( P = 0.54). No thrombotic complications occurred. Rates of red blood cell transfusions post‐paracentesis were similar between groups. Analysis of secondary end‐points identified significant differences in rates of withholding anticoagulation and mean change in haemoglobin between performing services.
Conclusion
Performance of abdominal paracentesis in patients receiving therapeutic or prophylactic anticoagulation appears to be safe regardless of whether anticoagulation was interrupted periprocedurally, with low rates of bleeding complications, thrombotic complications or need for red blood cell transfusions post‐paracentesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.
- Penn State College of Medicine, Hershey, Pennsylvania, USA.
ORCID-Profile: Joseph Raco
Förderung
- Penn State Milton S. Hershey Medical Center Department of Medicine Housestaff Grant
Zitieren
APA
Raco, J., Bufalini, J., Dreer, J., Shah, V., King, L., Wang, L., & Evans, M. (2025). Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants. Internal Medicine Journal. https://doi.org/10.1111/imj.16572
Vancouver
Raco J, Bufalini J, Dreer J, Shah V, King L, Wang L, et al. Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants. Internal Medicine Journal. 2025. doi:10.1111/imj.16572
BibTeX
@article{Raco2025,
author = {Raco, Joseph and Bufalini, John and Dreer, James and Shah, Vraj and King, Lauren and Wang, Li and Evans, Matthew},
title = {Safety of abdominal paracentesis in hospitalised patients receiving uninterrupted therapeutic or prophylactic anticoagulants},
journal = {Internal Medicine Journal},
year = {2025},
doi = {10.1111/imj.16572}
}
EUVIMED